Impact of atrial fibrillation phenotype and left atrial volume on outcome after pulmonary vein isolation
Europace · 30.03.2024 · 26 (4)
DOI: 10.1093/europace/euae071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 10.04.2024. Verfasst von Laurève Chollet und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Pulmonary vein isolation (PVI) is increasingly performed in patients with atrial fibrillation (AF). Both AF phenotype and left atrial (LA) volume have been shown to influence ablation outcome. The inter-relationship of the two is incompletely understood. We aimed to investigate the impact of AF phenotype vs. LA volume on outcome after PVI. Methods and results In a retrospective analysis of a prospective registry of patients undergoing a first PVI, the association of AF phenotype and LA volume index (LAVI) was assessed as well as their impact on AF recurrence during follow-up. Overall, 476 patients were enrolled (median age 63 years, 29% females, 65.8% paroxysmal AF). Obesity, hypertension, chronic kidney disease, and heart failure were all significantly more frequent in persistent AF. After 1 year, single-procedure, freedom from arrhythmia recurrence was 61.5%. Patients with paroxysmal AF had better outcomes compared with patients with persistent AF (65.6 vs. 52.7%, P = 0.003), as had patients with no/mild vs. moderate/severe LA dilation (LAVI <42 mL/m2 67.1% vs. LAVI ≥42 mL/m2 53%, P < 0.001). The combination of both parameters refined prediction of 1-year recurrence (P < 0.001). After adjustment for additional clinical risk factors in multivariable Cox proportional hazard analysis, both AF phenotype and LAVI ≥42 mL/m2 contributed significantly towards the prediction of 1-year recurrence.
Conclusion
Atrial fibrillation phenotype and LA volume are independent predictors of outcome after PVI. Persistent AF with no/mild LA dilation has a similar risk of recurrence as paroxysmal AF with a moderate/severe LA dilation and should be given similar priority for ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
ORCID-Profile: Salik Ur Rehman Iqbal, Severin Wittmer, Antonio Madaffari, Nikola Kozhuharov, Oskar Galuszka, Thomas Küffer, Christoph Gräni, Nicolas Brugger, Helge Servatius, Fabian Noti, Andreas Haeberlin, Laurent Roten, Hildegard Tanner, Tobias Reichlin
Zitieren
APA
Chollet, L., Iqbal, S. U. R., Wittmer, S., Thalmann, G., Madaffari, A., Kozhuharov, N., Galuszka, O., Küffer, T., Gräni, C., Brugger, N., Servatius, H., Noti, F., Haeberlin, A., Roten, L., Tanner, H., & Reichlin, T. (2024). Impact of atrial fibrillation phenotype and left atrial volume on outcome after pulmonary vein isolation. Europace, 26(4). https://doi.org/10.1093/europace/euae071
Vancouver
Chollet L, Iqbal SUR, Wittmer S, Thalmann G, Madaffari A, Kozhuharov N, et al. Impact of atrial fibrillation phenotype and left atrial volume on outcome after pulmonary vein isolation. Europace. 2024;26(4). doi:10.1093/europace/euae071
BibTeX
@article{Chollet2024,
author = {Chollet, Laurève and Iqbal, Salik Ur Rehman and Wittmer, Severin and Thalmann, Gregor and Madaffari, Antonio and Kozhuharov, Nikola and Galuszka, Oskar and Küffer, Thomas and Gräni, Christoph and Brugger, Nicolas and Servatius, Helge and Noti, Fabian and Haeberlin, Andreas and Roten, Laurent and Tanner, Hildegard and Reichlin, Tobias},
title = {Impact of atrial fibrillation phenotype and left atrial volume on outcome after pulmonary vein isolation},
journal = {Europace},
year = {2024},
volume = {26},
number = {4},
doi = {10.1093/europace/euae071}
}
EUVIMED